REFERENCES


  1. Hibbard JS
    Analyses comparing the antimicrobial activity and safety of current antiseptic agents: A review
    J Infus Nurs 2005; 28: 194-207
  2. Florman S, Nichols RL
    Current approaches for the prevention of surgical site infections
    Am J Infect Dis 2007; 3: 51-61
  3. Garcia R, Hibbard JS, Mulberry G et al
    Comparison of Chloraprep® and Betadine® as preoperative skin preparation antiseptics
    Abstracts of the Infectious Disease Society of America 40th Annual Meeting 2002: Abs 418
  4. Crosby CT, Mares AK
    Skin antisepsis: past, present, and future
    J Vasc Access Devices 2001; Spring: 26-31
  5. Data on file, Enturia
  6. Fredericks DN
    Microbial Ecology of Human Skin in Health and Disease
    J Invest Dermatol Symp Proc 2001; 6: 167-9
  7. Hendley JO, Ashe KM
    Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneum of human skin
    Antimicrob Agents Chemother 1991; 35: 627-31
  8. Milstone AM, Passaretti CL, Perl TM
    Chlorhexidine: Expanding the armamentarium for infection control and prevention
    CID 2008; 46: 274-80
  9. McDonald CP, Lowe P, Roy A
    Evaluation of donor arm disinfection techniques
    Vox Sanguinis 2001; 80: 135-41
  10. National Audit Office
    The management and control of hospital acquired infection in acute NHS trusts in England
    February 2000
  11. Plowman R, Graves N, Griffin M et al
    The socioeconomic burden of hospital acquired infection
    www.dh.gov.uk
  12. York N, Hartley-Jones c, Hutchinson J et al
    The cost-effectiveness of 2% chlorhexidine gluconate in 70% isopropyl alcohol in prevention of
    central venous access device-related infections in patients admitted to ITU
    Poster presented at 37th Annual Infection Control Conference,
    UK, September 2007
  13. Madeo M, Barlow G
    Reducing blood-culture contamination rates by the use of a 2% chlorhexidine solution applicator
    in acute admission units
    Hosp Infect 2008; 69: 307-9
  14. Ostrander RV, Botte MJ, Brage ME
    Efficacy of surgical preparation solutions in foot and ankle surgery
    J Bone Joint Surg Am 2005; 87: 980-5
  15. Casey AL, Itrakjy AS, Harbun C et al
    Prospective, randomised clinical trial to compare the efficacy of two 70% (v/v) isopropyl alcohol
    (IPA) solutions containing either 0.5% (w/v) or 2% (w/v) chlorhexidine gluconate (CHG) for skin
    antisepsis during coronary artery bypass grafting (CABG)
    Poster presented at European Congress of Clinical Microbiology and Infection Diseases
    (ECCMID), Spain, April 2008
 

Always Read
the Label

SmPC

PIL


MSDS

ChloraPrep with Tint

Clear

Information contained on this site pertains only to the United Kingdom.